Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics.

Orsolini L, Sceusa F, Pompili S, Mauro A, Salvi V, Volpe U

Open source

DOI
10.1080/14740338.2021.1928634
Published
2021 Oct
Container
Expert opinion on drug safety
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14740338.2021.1928634,
  title = {Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics.},
  author = {Orsolini L and Sceusa F and Pompili S and Mauro A and Salvi V and Volpe U},
  year = {2021},
  journal = {Expert opinion on drug safety},
  doi = {10.1080/14740338.2021.1928634},
  url = {https://doi.org/10.1080/14740338.2021.1928634}
}

RIS

TY  - JOUR
TI  - Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics.
AU  - Orsolini L
AU  - Sceusa F
AU  - Pompili S
AU  - Mauro A
AU  - Salvi V
AU  - Volpe U
PY  - 2021
JO  - Expert opinion on drug safety
DO  - 10.1080/14740338.2021.1928634
UR  - https://doi.org/10.1080/14740338.2021.1928634
ER  - 

APA

L, O., F, S., S, P., A, M., V, S., & U, V. (2021). Severe and persistent mental illness (SPMI) in pregnancy and breastfeeding: focus on second-generation long acting injectable antipsychotics.. Expert opinion on drug safety. https://doi.org/10.1080/14740338.2021.1928634

Source records